Ken Fisher Fisher Asset Management
AUM
$252B
1-Year Return
19.67%
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
This Quarter Return
+12.6%
1 Year Return
+19.67%
3 Year Return
+104.4%
5 Year Return
+153.45%
10 Year Return
+356.28%
AUM
$252B
AUM Growth
+$20.9B
(+9%)
Cap. Flow
-$2.43B
Cap. Flow
% of AUM
-0.96%
Top 10 Holdings %
Top 10 Hldgs %
30.76%
Holding
1,093
New
94
Increased
337
Reduced
522
Closed
107
Top Buys
| 1 |
Royal Bank of Canada
RY
|
$696M |
| 2 |
Sony
SONY
|
$424M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
$402M |
| 4 |
SAP
SAP
|
$354M |
| 5 |
Spotify
SPOT
|
$353M |
Top Sells
| 1 |
Oracle
ORCL
|
$1.91B |
| 2 |
NVIDIA
NVDA
|
$1.3B |
| 3 |
Salesforce
CRM
|
$1.04B |
| 4 |
Eli Lilly
LLY
|
$886M |
| 5 |
JPMorgan Chase
JPM
|
$868M |
Sector Composition
| 1 | Technology | 25.47% |
| 2 | Financials | 18.4% |
| 3 | Industrials | 9.35% |
| 4 | Healthcare | 9.18% |
| 5 | Communication Services | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
701
Universal Health Services
UHS
$12.1B
| $944K | ﹤0.01% |
5,212
+2,202
| +73% | +$399K |
|
702
PDF Solutions
PDFS
$788M
| $934K | ﹤0.01% |
43,679
-3,630
| -8% | -$77.6K |
|
703
Phillips 66
PSX
$53.2B
| $921K | ﹤0.01% |
7,720
+1,516
| +24% | +$181K |
|
704
Kroger
KR
$44.8B
| $915K | ﹤0.01% |
12,751
-2,318
| -15% | -$166K |
|
705
Reliance Steel & Aluminium
RS
$15.7B
| $908K | ﹤0.01% |
2,892
+7
| +0.2% | +$2.2K |
|
706
Cigna
CI
$81.5B
| $906K | ﹤0.01% |
2,741
+303
| +12% | +$100K |
|
707
Zymeworks
ZYME
$1.14B
| $903K | ﹤0.01% |
71,979
+5
| +0% | +$63 |
|
708
Movado Group
MOV
$431M
| $900K | ﹤0.01% |
59,013
+27,431
| +87% | +$418K |
|
709
SP Funds Dow Jones Global Sukuk ETF
SPSK
$351M
| $877K | ﹤0.01% |
48,129
+37,100
| +336% | +$676K |
|
710
Teledyne Technologies
TDY
$25.7B
| $872K | ﹤0.01% |
1,702
-830
| -33% | -$425K |
|
711
SPDR Portfolio S&P 500 ETF
SPLG
$83.8B
| $863K | ﹤0.01% |
11,875
-5,576
| -32% | -$405K |
|
712
PNC Financial Services
PNC
$80.5B
| $856K | ﹤0.01% |
4,593
+597
| +15% | +$111K |
|
713
Constellation Energy
CEG
$94.2B
| $855K | ﹤0.01% |
2,648
+444
| +20% | +$143K |
|
714
Viper Energy
VNOM
$6.29B
| $847K | ﹤0.01% |
22,223
-35,210
| -61% | -$1.34M |
|
715
iShares Core MSCI Emerging Markets ETF
IEMG
$103B
| $847K | ﹤0.01% |
14,109
-2,516
| -15% | -$151K |
|
716
SPDR Portfolio Developed World ex-US ETF
SPDW
$29.2B
| $826K | ﹤0.01% |
20,403
-4,255
| -17% | -$172K |
|
717
Vanguard Dividend Appreciation ETF
VIG
$95.8B
| $822K | ﹤0.01% |
4,015
-2,248
| -36% | -$460K |
|
718
iShares Russell Top 200 Growth ETF
IWY
$14.9B
| $821K | ﹤0.01% |
+3,329
| New | +$821K |
|
719
Aflac
AFL
$57.2B
| $813K | ﹤0.01% |
7,709
-1,781
| -19% | -$188K |
|
720
Verint Systems
VRNT
$1.23B
| $811K | ﹤0.01% |
41,214
-1,380,678
| -97% | -$27.2M |
|
721
Cogent Biosciences
COGT
$1.82B
| $796K | ﹤0.01% |
110,908
| – | – |
|
722
Invesco S&P MidCap Quality ETF
XMHQ
$5.12B
| $786K | ﹤0.01% |
+8,003
| New | +$786K |
|
723
Blackstone
BX
$133B
| $783K | ﹤0.01% |
5,235
-979
| -16% | -$146K |
|
724
Genpact
G
$7.82B
| $777K | ﹤0.01% |
17,646
-224
| -1% | -$9.86K |
|
725
Replimune Group
REPL
$494M
| $761K | ﹤0.01% |
81,949
| – | – |
|